Flexible models for better access

The issue of access to innovative medicines has become so pressing that the United Nations (UN) has set up a special working group to find ways to reconcile the high costs of developing new treatments with ensuring that health systems and patients can afford them. Richard Staines asks industry experts which initiatives are the most likely to bring these life-changing therapies to patients, given the financial and regulatory constraints. Read his feature article in pharmaphorum's digital magazine, Deep Dive: Market Access.